Lenalidomide Capsules are immunomodulatory antineoplastic medicines used primarily in the treatment of certain blood cancers and related disorders. Lenalidomide is commonly used in treatment regimens for multiple myeloma and certain myelodysplastic syndromes (MDS).

What are Lenalidomide Capsules?

Lenalidomide is the active ingredient in Lenangio. It has immunomodulatory and anticancer effects that help control the growth and survival of abnormal blood cells.

• Drug Classification: Immunomodulatory Agent / Antineoplastic
• Therapeutic Use: Anticancer / Hematology
• Route of Administration: Oral
• Active Ingredient: Lenalidomide

Benefits of Lenalidomide Capsules

Lenalidomide may be prescribed for:

• Multiple Myeloma: Used in combination with other anticancer medicines and, in appropriate patients, as maintenance therapy.
• Myelodysplastic Syndromes (MDS): Used for selected patients with specific forms of MDS.
• Certain Lymphomas: May be used in selected treatment settings under specialist supervision.

Its primary therapeutic benefit is to help control abnormal blood-cell growth and modify immune-system activity.

Dosage Guidelines

The dosage of Lenalidomide is determined by a qualified hematologist or oncologist based on the disease, treatment regimen, kidney function, blood counts, and response to treatment.

It is taken orally according to the prescribed treatment cycle. Dose adjustments may be required, particularly in patients with impaired kidney function or treatment-related blood-count abnormalities.

Lenalidomide Capsules Wholesale & Supply

Onco India International provides wholesale and bulk pharmaceutical supply of Lenalidomide products to eligible hospitals, pharmacies, healthcare providers, distributors, and other authorized buyers, subject to applicable regulations.

Buying Lenalidomide Capsules Online

Lenalidomide is a prescription oncology medicine and should be obtained through authorized pharmaceutical suppliers. Buyers should verify product authenticity, strength, manufacturer information, packaging, expiry date, and applicable regulatory requirements.

Reviews on Lenalidomide Capsules

Treatment response to Lenalidomide varies depending on the type and stage of disease, previous treatments, overall health, and combination therapy. Patient experiences should not replace advice from a qualified oncologist or hematologist.

Quality Assurance

Lenalidomide products supplied by Onco India International are intended to meet applicable pharmaceutical quality and regulatory requirements. Proper manufacturing, storage, packaging, and distribution practices are important for maintaining product quality.

Because Lenalidomide can cause blood-count abnormalities and other serious adverse effects, appropriate medical supervision and laboratory monitoring are important.

Frequently Asked Questions

1. What is Lenangio used for?
Lenangio contains Lenalidomide and is used in the treatment of certain blood cancers and blood disorders, particularly multiple myeloma and specific myelodysplastic syndromes.

2. How does Lenalidomide work?
Lenalidomide modifies immune-system activity and interferes with processes that support the growth and survival of abnormal blood cells.

3. Is Lenalidomide a chemotherapy medicine?
Lenalidomide is not a traditional cytotoxic chemotherapy drug. It is an immunomodulatory antineoplastic medicine.

4. Does Lenalidomide require blood tests?
Yes. Regular monitoring of blood-cell counts and kidney function may be required during treatment.

5. What are common side effects of Lenalidomide?
Possible side effects include fatigue, diarrhea, constipation, nausea, rash, and low blood-cell counts. Serious complications, including blood clots, may occur.

6. Can Lenalidomide be used during pregnancy?
No. Lenalidomide can cause severe birth defects and must not be used during pregnancy. Strict pregnancy-prevention measures are required.

Conclusion

Onco India International supplies and exports Lenalidomide Capsules (Lenangio) for pharmaceutical and oncology requirements, subject to applicable regulatory requirements. Lenalidomide is an immunomodulatory antineoplastic medicine used primarily in the treatment of multiple myeloma and certain blood disorders.

For safe and effective treatment, Lenalidomide should be used only under the supervision of a qualified hematologist or oncologist, with appropriate laboratory monitoring.